According to the Legislative Budget Board (LBB), HB 3749 is not expected to have a significant fiscal impact on the State of Texas. The regulatory framework established by the bill, governing the delegation and administration of elective intravenous (IV) therapy, can be implemented using existing resources within the relevant state agencies. These include the Texas Medical Board and the Texas Department of Licensing and Regulation, which are not anticipated to require additional funding or staffing to accommodate the bill's provisions.

Similarly, the bill is not expected to create a significant fiscal burden on local governments. Since HB 3749 focuses on clarifying delegation authority within already licensed healthcare professions and does not establish new regulatory bodies or enforcement mandates at the local level, it does not impose new administrative or financial obligations on municipalities, counties, or local health authorities.

Overall, HB 3749 achieves its regulatory goals with minimal financial impact by relying on existing licensing and supervisory structures within the state’s healthcare oversight system. Its implementation is expected to be cost-neutral for both state and local entities.

While HB 3749, Jenifer’s Law, is well-intentioned in its goal of addressing patient safety in the growing elective intravenous (IV) therapy market, it raises legitimate concerns about expanding state regulation into a field that has, until now, been largely governed by market forces and existing medical licensing laws. The bill establishes statutory provisions for delegating the prescribing and administration of elective IV therapy, creating additional legal structure around an activity already covered under existing delegation laws in the Texas Occupations Code. For proponents of limited government, this formalization may be seen as unnecessary and potentially intrusive.

The bill does not create new agencies or impose direct costs on taxpayers. However, it adds a layer of statutory specificity that will likely be interpreted and enforced by licensing boards, which can evolve into broader regulatory oversight in future sessions. Additionally, the bill removes flexibility currently afforded under Section 157.0512(d) of the Occupations Code by explicitly denying prescriptive authority exceptions for elective IV therapy, including in medically underserved areas and certain facility-based practices. This limits medical providers' discretion and may have the unintended effect of reducing access to services in precisely the communities that need alternatives the most.

HB 3749 could also chill innovation in the wellness sector by effectively tethering non-physician providers, such as IV clinics and mobile health startups, to formalized supervisory structures. These businesses may already be operating responsibly under existing law, and codifying new rules could create compliance burdens that disproportionately impact small operators. Entrepreneurs offering low-risk hydration and vitamin therapies might now face increased legal liability, administrative hurdles, or difficulties securing physician supervision, all of which could drive up costs or deter market entry.

Finally, this bill may set a precedent for future legislation aimed at elective or lifestyle-oriented health services, opening the door to broader regulation of the wellness industry. Even narrowly written statutes can expand over time through rulemaking or litigation. For legislators committed to minimizing regulatory creep and preserving individual responsibility and market choice in healthcare, these risks warrant serious consideration.

In sum, although HB 3749 seeks to protect patients, it does so by introducing new statutory controls that may not be necessary and that risk undermining key conservative principles: limited government, personal freedom, professional discretion, and free enterprise. For those reasons, Texas Policy Research recommends that lawmakers vote NO on HB 3749.

• Individual Liberty: The bill supports individual liberty by seeking to protect patients from unsafe or unregulated medical practices, particularly in light of tragic incidents involving elective IV therapy. It ensures that these services are delivered under the supervision of licensed professionals, potentially reducing the risk of harm. However, it may restrict patient choice by indirectly reducing access to elective IV treatments in settings that cannot meet the new delegation or supervision requirements. For individuals seeking low-risk wellness treatments outside traditional medical contexts, this may limit their freedom to make personal health decisions without state interference.
• Personal Responsibility: By codifying who may provide elective IV therapy and under what conditions, the bill reduces the ability of patients and providers to assume responsibility for their own choices and outcomes. Where individuals previously could choose to receive these treatments from providers operating within general medical standards, the bill replaces that choice with prescriptive legal requirements. This shift may subtly diminish a culture of personal accountability and informed consent in favor of top-down regulatory compliance.
• Free Enterprise: The bill imposes regulatory boundaries that could restrict innovation and competition in the elective wellness market. By requiring physician supervision and placing limits on who may delegate or administer IV therapy, the bill may raise operating costs, create new legal risks, and deter entry by small or mobile businesses. In particular, clinics not owned or operated by physicians may find it harder to offer services legally, especially in rural areas where supervision may be difficult to obtain. These constraints work against the principle of free enterprise and open market access.
• Private Property Rights: The bill does not directly regulate the use or ownership of property. However, it may indirectly affect how business owners can use their property—such as mobile IV units or retail wellness spaces—by limiting the services they can legally provide without physician oversight. This could place practical limits on how individuals use their property for lawful commerce, though it stops short of infringing on ownership or use rights.
• Limited Government: Though fiscally minimal, the bill represents an expansion of the regulatory state. It inserts new statutory language into the Occupations Code, tightens existing delegation exceptions, and restricts prescriptive flexibility that physicians currently have in underserved areas. Even though no new agencies or licensing systems are created, the bill formalizes state control over a sector that had previously been managed through general health and safety laws. This approach conflicts with the principle that the government should regulate only when absolutely necessary, and then in the least intrusive way possible.